Gonadorelin is a synthetic decapeptide identical in sequence to endogenous gonadotropin-releasing hormone (GnRH), the hypothalamic neuropeptide responsible for controlling the release of LH (luteinizing hormone) and FSH (follicle-stimulating hormone) from the anterior pituitary. Its sequence is pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, representing the complete native GnRH molecule.
Researchers have studied Gonadorelin for its pulsatile stimulation of gonadotropin release from pituitary gonadotroph cells. Research has characterized how the frequency and amplitude of GnRH pulses differentially regulate LH versus FSH secretion – a key principle in reproductive endocrinology. Studies have examined how Gonadorelin administration at different pulse frequencies can either stimulate or paradoxically suppress gonadotropin release, the latter being the basis of continuous GnRH agonist use in research models.
Preclinical research has used Gonadorelin to study HPG axis dynamics, pituitary responsiveness testing, and experimental models of reproductive function. Studies have explored its role in studying spermatogenesis support through LH-mediated testosterone production and FSH-mediated Sertoli cell function. Its sequence identity with native GnRH makes it the reference compound for studying the GnRH receptor and hypothalamic-pituitary-gonadal axis signaling.
For research use only. Not for human consumption. Iron Prairie Labs products are intended for qualified researchers and laboratory use only.
